Gynecological Drugs Market - Global Industry Analysis

Gynecological Drugs Market

Gynecological Drugs Market Size, Share, Growth Report & Forecasts by 2028

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3926 Published Date: Mar-2019 Status : Published

Table Of Content


Free Analysis

The treatment of gynecological ailments is purely drug-dependent. In recent times, the gynecological pharmacology field has bloomed like never before. Furthermore, the availability of the ultraprecise advanced gynecological investigation, direct monitoring facility, and various medical options for the treatment of gynecological ailments is increasing. With the establishment of down and up-regulation policies, the different treatment options, such as hypothalamus and pituitary, have now become a very easy tool for gynecologists to treat hormonal disorders. These gynecological disorders include conditions affecting ovaries, uterus, and their appendages.

There are various factors expected to support the growth of the global gynecological drugs market in the future, such as the increasing prevalence of gynecological diseases. Changing lifestyle of females across the globe has eventually put them at a higher risk of suffering from various types of gynecological disorders, which, in turn, is fuelling the global gynecological drugs market. The awareness about one’s well-being and health has increased, which has led to the rise for better gynecological treatments and the manufacturers have innovated newer drugs for treating gynecological disorders with fewer side-effects and better efficacy. These are also projected to fuel this global market.

Global Gynecological Drugs Market

The gynecological drugs market is segmented into the distribution channel, therapeutics, and indication. Based on therapeutics, the market is segmented into hormonal therapy and non-hormonal therapy. Non-hormonal therapy is expected to hold the major market share over the estimated timeline. Based on the indication, the market is segmented into gynecology infections, gynecology cancers, endometriosis, polycystic ovary syndrome, female infertility, menopausal disorder, contraception (birth control), and others. Polycystic ovary syndrome is expected to grow significantly over the forecast timeline. Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies held the major share of the global market in 2018.

North America is expected to lead the global gynecological drugs market over the forecast timeline, due to the high expenditure on women’s health, substantial research and development activities witnessed in the gynecology domain. Europe is predicted to trail behind North America in terms of growth and be the second largest gynecological drugs market in the years ahead. Asia Pacific is likely to record a high CAGR over the forecast timeframe, owing to the introduction of new and approved gynecological drugs, the presence of strong healthcare infrastructure, increased affordability of the gynecological drugs, and technological advancements.

Some key players of the gynecological drugs market are Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Pfizer, Inc., Amgen Inc., AstraZeneca, Allergan, and Bayer AG, among others.

Choose License Type

  • zion payment modes


Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed